Gynae BT 2017

Serous and clear cell

➢ Stage I serous and clear cell •

103 patients: 26% non-invasive; 58% <50% invasion • 34% received adjuvant chemotherapy • 5-year isolated pelvic recurrence rate 4%, locoregional recurrence 7% • 5-year OS 84%

➢ Vaginal brachytherapy alone sufficient in stage IA

Barney BM. IJROBP 2013